Cite
Apalla Z, Spyridis I, Kyrgidis A, et al. Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety. J Am Acad Dermatol. 2020;85(6):1589-1592doi: 10.1016/j.jaad.2020.11.036.
Apalla, Z., Spyridis, I., Kyrgidis, A., Lazaridou, E., Kyriakou, A., Fotiadou, C., Pikou, O., Sotiriou, E., Vakirlis, E., Papageorgiou, C., Delli, F., Moutsoudis, A., Manoli, S. M., Ioannides, D., & Lallas, A. (2021). Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety. Journal of the American Academy of Dermatology, 85(6), 1589-1592. https://doi.org/10.1016/j.jaad.2020.11.036
Apalla, Zoe, et al. "Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety." Journal of the American Academy of Dermatology vol. 85,6 (2021): 1589-1592. doi: https://doi.org/10.1016/j.jaad.2020.11.036
Apalla Z, Spyridis I, Kyrgidis A, Lazaridou E, Kyriakou A, Fotiadou C, Pikou O, Sotiriou E, Vakirlis E, Papageorgiou C, Delli F, Moutsoudis A, Manoli SM, Ioannides D, Lallas A. Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety. J Am Acad Dermatol. 2021 Dec;85(6):1589-1592. doi: 10.1016/j.jaad.2020.11.036. Epub 2020 Nov 27. PMID: 33253837.
Copy
Download .nbib